Anthraquinones/administration & dosage; Anthraquinones/pharmacology; Anti-Inflammatory Agents/administration & dosage; Anti-Inflammatory Agents/pharmacology; Colorectal Neoplasms/drug therapy; Inflammatory Bowel Diseases/drug therapy; T-Lymphocytes/drug effects; Administration, Oral; Animals; Anthraquinones/toxicity; Cell Survival/drug effects; Colon/cytology; Colon/drug effects; Colon/metabolism; Colorectal Neoplasms/pathology; Cytokines/genetics; Cytokines/metabolism; Dextran Sulfate/toxicity; Female; HT29 Cells; Humans; Inflammatory Bowel Diseases/chemically induced; Interleukin-1beta/genetics; Interleukin-1beta/metabolism; Interleukin-8/genetics; Interleukin-8/metabolism; Lymph Nodes/drug effects; Lymph Nodes/metabolism; MAP Kinase Signaling System/drug effects; Mice; Mice, Inbred C57BL; T-Lymphocytes/immunology; Tumor Necrosis Factor-alpha/genetics; Tumor Necrosis Factor-alpha/metabolism; Tumor Necrosis Factor-alpha/pharmacology

DSS-induced IBD; HT-29; chrysophanol; colitis; colorectal cells; effector T cells; immunosuppressive; pro-inflammatory cytokines